Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) in Primary Autonomic Failure
NCT02591173Phase 1Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2016
- Primary completion
- Jul 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of angiotensin-(1-7) in Supine hypertension (SH) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Blood Pressure at 50 minutes. Started Feb 2016; status: terminated.
02
Drugs
angiotensin-(1-7)
03
Conditions
Supine hypertension (SH)
Beyond the preview
Go deeper on NCT02591173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02591173.